First a message from our friends at The Oxford Club [sponsor]
For 137 years now…
A little-known public land trust has been quietly sitting on millions of acres of American land...
Paying royalties on every drop of energy that gets pulled out of the ground.
Oil. Natural gas. Even water.
Every barrel. Every cubic foot. Every gallon.
The checks just keep rolling in.
It’s so profitable… a single $1,000 investment since January 2000 turned into $556,000!
That works out to a 29% return… every year for 25-straight years.
You can check out the details by clicking here.
But get this…
Donald Trump just TURBOCHARGED the entire opportunity…
He just pledged $500 billion to develop massive new AI data centers – and he’s beginning with this specific area.
More drilling means more royalties.
More royalties mean bigger payouts.
Bigger payouts mean even better returns for anyone holding what I call "The 29% Account."
The big banks figured this out decades ago.
BlackRock, Wells Fargo, JPMorgan – they've all quietly parked billions here.
Now you can do the same.
Good investing,
Marc Lichtenfeld
Chief Income Strategist, The Oxford Club
P.S. This account is open to any American – no matter your age or income. Click here to see how it works.
FEATURED ARTICLE
Big Winners, Big Losers: The Real Drivers Behind Today’s Moves
This morning’s tape is a classic “macro week hangover”: traders are coming off Friday’s huge rally, but nobody wants to press big directional bets ahead of Wednesday’s delayed January jobs report and Friday’s CPI.
That shows up in the scoreboard:
SPY is modestly higher on the session (around +0.1% mid-day), but not extending aggressively.
QQQ is also slightly higher (around +0.2%), suggesting mega-cap/growth is steadier than the broad market.
IWM is basically flat/slightly red, implying small caps are not following through.
That combination—large-cap steadier, small caps lagging—usually means the market is in “wait-and-see” mode: risk is being expressed selectively, and big money is keeping powder dry until the next macro print.
Below is the deep dive on what’s moving, why it’s moving, and what it means for active traders.
1) The Big Picture: Friday’s “rip” meets a macro data wall
Friday wasn’t just a green day—it was an event. The Dow finished the week with a surge that pushed it above 50,000, while the S&P 500 logged its biggest one-day pop since May 2025.
Now the market is trying to answer a tougher question:
Was Friday’s rally a durable re-risking… or a positioning snapback before the next data shock?
This morning’s price action leans toward “snapback, cautious follow-through”:
Futures were modestly higher heading into the session, but not exploding upward.
Most moves are idiosyncratic (earnings/regulatory headlines) rather than broad “risk-on” buying.
That’s a very specific regime:
Macro uncertainty suppresses index momentum, while single-name headlines create outsized dispersion.
For traders, dispersion is opportunity—if you’re disciplined about catalysts and risk.
2) Why the market feels “uneasy” even as the indices hold up
A) The calendar is doing the heavy lifting
This is not a normal Monday. Investors are staring at:
Employment Situation (Jan 2026) on Wednesday
CPI on Friday
In weeks like this, the market often trades in two phases:
Positioning / range trade into the data
Repricing after the data (rates move first, then equities follow)
So, if you’re wondering why the tape looks “indecisive,” it’s because a lot of desks don’t want to be heroes until they see the inflation and labor prints.
B) Cross-asset tells: crypto bounce, oil softness, metals firming
MarketWatch noted bitcoin rebounded toward ~$71k after a sharp drop, while gold and silver also bounced and oil fell amid geopolitical chatter.
Even if you don’t trade those markets, they matter because they influence:
inflation expectations (oil),
risk appetite (crypto),
and “flight to safety” behavior (gold).
When those are moving at the same time as major macro data looming, equity traders tend to keep sizing smaller and timeframes shorter.
3) The morning’s biggest “real” movers (and the real reasons)
Mover #1: Kyndryl (KD) — the kind of drop that changes a chart for months
KD isn’t down because “growth is slowing.” It’s down because the market is repricing credibility risk.
What happened:
Kyndryl’s stock is getting crushed after earnings and a major corporate governance / reporting shock: an accounting review, delayed SEC filing, expectation of material weaknesses in internal controls, and a CFO departure.
On the fundamentals, guidance was cut: revenue outlook shifted from expected growth to a projected decline (constant currency), and free cash flow guidance was reduced meaningfully.
Barron’s also reported the quarter missed expectations (adjusted EPS and revenue below consensus) and highlighted the leadership instability as a key confidence hit.
Why traders care:
This is not a “miss by a penny.” It’s a risk-premium reset:
When internal controls become part of the story, institutions often step aside until clarity returns.
Even “cheap” valuations stop mattering short-term, because buyers demand a bigger discount for uncertainty.
How to think about it tactically (suggestive):
This type of news often creates a multi-day volatility window, not a one-and-done.
If you trade it, it’s typically an options market / mean-reversion battlefield, not a clean directional trend—until volume and price stabilize.
For most active traders, the higher-quality move is often: don’t catch it today; watch for a base and confirm that the selling becomes orderly.
Mover #2: Hims & Hers (HIMS) — regulatory risk just went from “background” to “front page”
HIMS is the archetype of what happens when a growth story leans hard on a product strategy that regulators can disrupt.
What happened (the headline driver):
Hims abruptly halted access to a compounded oral semaglutide (“Wegovy-like”) product after regulatory pressure escalated—HHS referred the matter to DOJ, and FDA scrutiny increased around compounded GLP-1 products.
As a result:
HIMS dropped sharply this morning.
Meanwhile Novo Nordisk (NVO) surged on the idea that copycat pressure may ease, and Reuters reported Novo filed a lawsuit alleging patent infringement in the wake of the episode.
Why the market is reacting so violently:
This isn’t just “one pill.” It’s the market asking:
How much of HIMS growth is tied to the GLP-1 compounding ecosystem?
How durable is that revenue if ingredient access gets restricted or enforcement ramps?
When regulators enter the chat, multiples can compress fast because the market can’t model the next move with confidence.
Tactical read (suggestive):
If you’re trading HIMS, the “support” level isn’t just a line on a chart—it’s news flow.
Watch whether follow-up statements or legal developments stabilize sentiment, or whether this becomes a rolling story with additional enforcement actions.
If you’re looking for the “other side” trade, today’s action shows how the market is treating brand-protected incumbents (Novo, Lilly) as beneficiaries of a crackdown.
Mover #3: Novo Nordisk (NVO) and Eli Lilly (LLY) — winners by default in a crackdown
When a “copycat” threat fades, the original IP owners can trade like they just got a surprise tailwind.
Barron’s and Reuters both framed the market’s reaction clearly:
HIMS down,
Novo up ~high single digits,
Lilly up as well, as the market prices in reduced competition from compounded alternatives.
Why this matters beyond today:
This is a reminder that some of the biggest “market moves” don’t start with CPI—they start with policy enforcement.
And for traders, that’s a distinct edge:
CPI moves the index.
Regulatory action can create single-name re-ratings that last weeks.
Mover #4: monday.com (MNDY) — “Beat-and-drop” is a 2026 software theme
MNDY is getting punished despite beating on the quarter because the market is allergic to guidance risk in software right now.
Barron’s reported:
Adjusted EPS beat (about $1.04 vs $0.92 expected)
Revenue beat ($333.9M vs $329.7M expected)
But 2026 operating income guidance ($165M–$175M) was far below the Street ($218M), and full-year revenue guidance also came in light.
This is the key point:
In a “macro-sensitive” tape, investors don’t pay for what you did—they pay for what you say you’ll do next.
What to watch:
Is this a one-day reset, or does the stock keep bleeding as funds rebalance software exposure?
In software, “guide-down” moves often produce a second-leg if broader growth sentiment is weak.
Tactical framing (suggestive):
The higher-probability trade often isn’t the open—it’s the post-initial flush when price either:
starts building a base with decreasing sell volume, or
fails weakly into the close (bearish continuation signal).
Mover #5: Pagaya (PGY) — earnings nuance gets lost when the revenue line misses
This morning’s PGY action is a clean example of how markets behave when volatility is elevated: they simplify the story.
Stocktwits/MarketBeat/Investing.com coverage indicates the quarter featured:
profitability/cash generation metrics that sound constructive (MarketBeat highlighted GAAP net income and operating cash flow),
but revenue came in below expectations, which was enough to trigger a sharp selloff.
Why a revenue miss matters so much for names like PGY:
Fintech multiples are highly sensitive to top-line trajectory and credit narrative.
When the market is jittery, “miss = de-risk” becomes the rule, even if other metrics improved.
Tactical framing (suggestive):
If you trade PGY, you need a thesis about what the market will care about next:
If it’s revenue re-acceleration, today’s move might persist.
If the market shifts back to rewarding cash generation, the stock can stabilize faster than expected.
Either way, the first 1–2 hours after earnings is often price discovery, not the “final word.”
4) Tesla (TSLA) — not the main mover, but still a sentiment tell
Barron’s noted Tesla was down slightly this morning (around flat-to-down), after a rebound Friday, with investors still looking for tangible catalysts like robotaxi expansion or robotics milestones.
Tesla matters in this context because it’s often a risk appetite proxy:
If TSLA and high-beta growth lead, risk-on is broadening.
If TSLA drifts while defensives hold, the market is still cautious.
Today, Tesla reads more like “waiting room,” consistent with the macro-overhang regime.
5) What today’s winners and losers are really saying about the market
When you zoom out, the message is coherent:
The market is rewarding:
legal/IP-protected incumbents when regulators clamp down on substitutes (Novo/Lilly)
companies that can guide confidently in spite of macro noise
The market is punishing:
credibility shocks (KD accounting review + guidance cuts)
regulatory model risk (HIMS GLP-1 compounding scrutiny)
software guidance misses (MNDY)
earnings where the “headline line” (revenue) misses, even if other pieces are strong (PGY)
That’s not random. It’s a market pricing uncertainty aggressively.
6) Active Trader “Action Plan” for the rest of today (suggestive, not definitive)
A) Trade the regime, not your opinions
With SPY/QQQ only modestly green and macro data ahead, assume:
fewer clean trends
more headline-driven spikes
more mean reversion
So:
avoid oversized directional index bets unless breadth expands meaningfully,
focus on catalyst stocks with clear drivers (earnings, regulatory, guidance).
B) Watch the “quality of the bid” into the close
In macro weeks, the close matters:
If the market fades all day, it signals positioning is still defensive.
If it firms into the close, it suggests funds are willing to carry risk into the week’s data.
C) If you’re trading these movers specifically
KD: treat it as a volatility event. If you don’t have an edge in chaotic tape, the best trade is often no trade until it stabilizes.
HIMS: trade the news cycle. Watch for follow-on legal/regulatory headlines; avoid assuming “it’s done” after the first drop.
NVO/LLY: strength here is a signal that the market is rewarding IP and regulatory moats today.
MNDY: guidance is the story—watch whether the stock can base intraday or whether sellers keep pressing into the close.
PGY: separate the “headline miss” from the underlying cash/profit narrative—if it can’t reclaim key levels after the first wave, momentum traders will lean on it.
Editorial Disclaimer
This commentary is for informational and educational purposes only and does not constitute investment advice. All market strategies involve risk, and past performance is not indicative of future results. Readers should conduct their own analysis or consult a licensed financial professional before making investment decisions.